Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
[73]
RCT |
87 people |
Adverse effects
5/44 (11%) with PGE1 (60 mg/day infused over 2 hours) 2/43 (5%) with placebo |
Significance not assessed |